Trudy from Spain

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Canopy Growth Corp. (CGC) shares information

Canopy Growth Corp.


24h Change

1.36 %

CGC

Live rate: Market closed

Stock data per Tuesday 4 Aug, 2020

CGC
New York Stock Exchange
19.06
18.96
19.32
0.26 (+ 1.36%)
US Market is closed

Live Stock price in graph for Canopy Growth Corp. (CGC)

  • Latest Volume

    5,687,674 (36.93 %)

  • Volume prev. day

    4,153,604

  • Avg. daily volume

    4,136,376

  • Market cap

    7,147,221,480

  • P/E ratio

    -2.92

  • Today high

    19.66

  • Today low

    18.7

  • 52 week high

    34.34

  • 52 week low

    9

  • YTD Change

    n/a

Quick links

Broker recommendations for Canopy Growth Corp.

The Canopy Growth Corp. stock is rated at 1.928571 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Monday 1 June, 2020 by a total of 21 brokers. This means that the consensus of the 21 different brokers is leaning toward to moderate buy/hold.

Sell
3 (14.29%)
Underweight
0 (0%)
Hold
13 (61.9%)
Overweight
1 (4.76%)
Buy
4 (19.05%)

Price target by analysts

The 19 latest analyst estimates, per Thursday 30 July, 2020, show the following high, low and average price targets.
Target Average: 17.39 USD
Target High: 23 USD
Target Low: 11.67 USD

 

Latest news about Canopy Growth Corp.

Below you can find the most recent news posts about Canopy Growth Corp., primarily from US and UK based news sources.

Sol Clahanem Canopy Growth’s VP And General Manager, U.S. Region, Joins The Benzinga Cannabis Advisory Council

Tuesday, 4 August 2020, 21:44:27
Sol Clahane, vice president and general manager for the U.S. region for Canopy Growth Corp. (NYSE: CGC ) has joined the Benzinga Cannabis Advisory Council , ahead of our August 18 Virtual event . Clahane oversees all Canopy Commercial operations and brands available in the U.S. market, including BioSteel, First & Free, This Works and the Martha Stewart CBD product portfolio. She is responsible for the growth of the region, leading sales strategies and business development across the country. “I’m thrilled to represent Canopy Growth as part of the Benzinga Cannabis Advisory Council, and look forward to working with this impressive group of industry peers to share insights and advance a common agenda,” said Clahane. Prior to joining Canopy, Clahane served as the Vice President and General Manager of US Chains for Pernod-Ricard, where she led the strategic planning for channel and customer development as well as customer marketing, shopper insights and category management. She has also held senior roles at iconic global brands, such as Brown-Forman, Coca-Cola and Pepsi.
— Benzinga


Cannabis Movers & Shakers: MPXI, Benzinga, RespireRx, MedMen, Medipharm

Tuesday, 4 August 2020, 17:01:22
Here comes another Tuesday, with the latest updates on leaderhip changes within the cannabis industry. MPXI Part Ways With David McLaren, Appoints Interim CFO MPX International Corp. (CSE: MPXI), which recently partnered with Medical Cannabis by Shoppers Drug Mart Inc. to develop clinical services for Shopper Drug Mart’s patients, has parted ways with David McLaren, who served as CFO. The decision is effective July 31. The Toronto-based company tapped Jonathan Chu to replace McLaren in the position as interim CFO. MPXI chief executive W. Scott Boyes thanked McLaren for his contributions, adding that Chu “will succeed in shepherding MPXI’s finance and accounting functions.” Chu has been with MPXI since February 2019. Canopy Growth Corp.’s Sol Clahane Joins Benzinga Cannabis Advisory Council Benzinga tapped Sol Clahane , Canopy Growth Corp. ‘s (NYSE: CGC ) vice president and general manager for the U.S. region, for its Benzinga Cannabis Advisory Council . The Detroit-based financial news and data company also welcomed SLANG Worldwide’s President and CEO Chris Driessen to the council.
— Benzinga


Will Cannabis Entrepreneurs Switch to Psychedelics?

Saturday, 1 August 2020, 16:33:05
The psychedelics space is heating up, and major players have taken notice. The market is bolstered by a growing number of decriminalization movements across the United States, as well as an increasing number of market participants, including names like Champignon Brands (CSE: SHRM), Hollister Biosciences (CSE: HOLL) and Revive Therapeutics (CSE: RVV). Cannabis companies are joining the market , as are notable leaders from the marijuana space. Notable names include former Canopy Growth Corp (NYSE: CGC ) CEO Bruce Linton, now a director for Toronto’s Mind Medicine (MindMed) Inc (OTCMKTS: MMEDF) and chairman of the advisory board for Red Light Holland (CNSX: TRIP), a brand focused on truffles. In June 2020, Aurora Cannabis (NYSE: ACB ) co-founder Terry Booth left his cannabis venture. In doing so, Booth has shifted attention towards psychedelics, investing in Red Light Holland. Booth also joined Psyched Wellness Corp.’s board in May 2020. What’s the Appeal of Psychedelics? Those who spoke to Benzinga for this article believe that the interest in the emerging space stems from creating a medical impact as well as cannabis regulatory frustrations.
— Benzinga


The Week In Cannabis: Strong Earnings, Stocks In Green, Investments And Divestments

Friday, 31 July 2020, 23:59:36
Cannabis stocks, and overall markets, closed the week in the green, as cannabis companies got into their earnings season. “Earnings season is just starting to come to life as Scotts Miracle Gro (NYSE: SMG )’s Hawthorne group just crushed it,” Debra Borchardt, Editor-In-Chief of Green Market Report told Benzinga. “Things are going so well over at Scotts that even the non-bonus employees received bonuses. How rare is that in this pandemic economy and how nice of a company to share the wealth with everyone.” Also reporting earnings this week was Aphria Inc. (TSX: APHA) (NASDAQ: APHA ), which achieved its fifth consecutive quarter of growth. The Leamington, Canada-based company reported a year-over-year revenue spike of81% to CA$53.1 million (US$39.7 million). Adult-use cannabis revenue amounted to CA$56.7 million, up by 27% sequentially, according to its fourth-quarter earnings report. Aphria generated CA$152.2 million in overall net revenue, seeing a sequential and year-over-year increase of 5% and 18%, respectively. “Our strong finish to fiscal year 2020 demonstrates that this was a transformative year for Aphria, as our net revenue increased 129% from fiscal year 2019,” noted Chairman and CEO Irwin Simon.
— Benzinga


Canopy Growth to Report First Quarter Fiscal 2021 Financial Results on August 10, 2020

Friday, 31 July 2020, 13:00:00
SMITHS FALLS, ON, July 31, 2020 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) will release its financial results for the first quarter fiscal 2021 ended June 30, 2020 before financial markets open on August 10, 2020. Following the…
— PR Newswire